The immune system relies on B cells and their ability to make antibodies against an extremely broad range of pathogens. This broad responsiveness bears some risk, as B cells can also turn against healthy tissue - a phenomenon called autoimmunity. Scientists from the lab of Meinrad Busslinger now reported in the journal “Nature Immunology” how the protein Ikaros orchestrates the fine balance between B cell silencing and activation - and thereby controls autoimmunity.
B cells are white blood cells that generate antibodies against an almost unlimited number of pathogens, a capacity that is vital for any higher organism. However, establishing a diverse repertoire of pathogen recognition comes at a price, as some B cells will inevitably go wild and turn against the organism’s own healthy tissue.
Such autoreactive B cells need to be silenced and are kept within the pool of B cells for emergencies, such as serious infections, for which no specific B cell can be found in the active B cell pool.
Scientists from the lab of the IMP Deputy Director Meinrad Busslinger have investigated the two antagonistic mechanisms that silence or awaken autoreactive B cells. Both mechanisms are controlled by the protein Ikaros, thereby controlling autoimmunity – as now reported in the journal Nature Immunology.
Remarkably, the starting point of the project was not autoimmunity, but an interest in how the transcription factor Ikaros may influence B cell differentiation.
Transcription factors are proteins that bind to specific parts of the DNA to activate or repress certain genes. “When you are interested in how a transcription factor works, you normally start by looking at what it does early or late in B cell development, and you can do so by selectively inactivating the factor”, says Meinrad Busslinger in explaining the chosen approach.
In the absence of Ikaros in mature B cells of mice, the scientists observed a high degree of autoimmunity. This made them turn to the two mechanisms that switch B cells on and off: “Anergy” of the B cell antigen receptor (BCR) is a tolerance mechanism that makes autoreactive B cells insensitive to self-antigens, and “Toll-like receptor (TLR)” signalling awakens B cells.
“We could show that in the absence of Ikaros, BCR anergy decreases, TLR signalling increases, and B cells become hyperactive leading to systemic autoimmunity in the animals”, says Tanja Schwickert, first author of the study, who continued to investigate how Ikaros specifically controls the two mechanisms causing these signalling defects. The results supported the main conclusion of the study: “Ikaros acts as a guardian that prevents autoimmunity.”
The research project started with the development of a mouse model to study the function of Ikaros in mature B cells in 2012. “At this point, nobody could have guessed that we will identify Ikaros as a fundamental regulator of autoimmunity”, says Meinrad Busslinger. He now considers the establishment of this link to be a case of serendipity:
“This is how basic research works – you ask a fundamental question, and you work out mechanisms with unexpected, but very far-reaching implications for all sorts of phenomena”. In this case, two mechanisms were discovered through which a single protein is sufficient to control autoimmunity.
In humans, Ikaros mutations have been identified as a risk factor for systemic lupus erythematosus (SLE), an autoimmune disease that cannot be cured and drastically shortens the life expectancy of affected patients. The present study will help to bring this condition into context of a basic mechanism that could be involved in the generation of autoimmune disease.
About the IMP at the Vienna BioCenter
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. The IMP is located at the Vienna BioCenter, one of Europe’s most dynamic life science hubs with 1,800 employees from 70 countries in four research institutes, three universities and two dozen biotech companies.
Tanja A. Schwickert, Hiromi Tagoh, Karina Schindler, Maria Fischer, Markus Jaritz and
Meinrad Busslinger. Ikaros prevents autoimmunity by controlling anergy and Toll-like receptor signaling in B cells. Nature Immunology, doi:10.1038/s41590-019-0490-2.
Dr. Heidemarie Hurtl IMP Communications | idw - Informationsdienst Wissenschaft
Human skin is an important source of ammonia emissions
27.05.2020 | Max-Planck-Institut für Chemie
Biotechnology: Triggered by light, a novel way to switch on an enzyme
27.05.2020 | Westfälische Wilhelms-Universität Münster
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
28.05.2020 | Transportation and Logistics
28.05.2020 | Physics and Astronomy
28.05.2020 | Power and Electrical Engineering